Organic Juices Market to Touch USD 60.2 Billion by 2030 at 9-03-2023, 22:29

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

BitMEX Introduces Free Bitcoin Spot Trading Until Bitcoin Hits $100,000 29-04-2025, 19:00